| |
| |
|
| Insider
Information: |
Young Jonathan |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
258,306 |
|
|
Indirect Shares
|
60,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
318,306 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
|
2024-05-01 |
258,306 |
2024-05-01 |
60,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRO |
Akero Therapeutics, Inc. |
EVP, Chief Operating OfficerOf |
• – – |
2019-06-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
60,000 |
|
- |
|
| AKRO |
Akero Therapeutics, Inc. |
EVP, Chief Operating OfficerOf |
• – – |
2019-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
192,909 |
|
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2019-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
667 |
193,576 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2020-01-10 |
4 |
OE |
$0.62 |
$23,928 |
D/D |
38,907 |
232,483 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2020-03-13 |
4 |
OE |
$0.62 |
$6,837 |
D/D |
11,117 |
183,600 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2020-06-30 |
4 |
A |
$17.07 |
$21,250 |
D/D |
1,245 |
184,845 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-01-04 |
4 |
AS |
$25.27 |
$77,399 |
D/D |
(3,060) |
181,785 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-01-07 |
4 |
OE |
$0.62 |
$4,613 |
D/D |
7,500 |
189,285 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-01-08 |
4 |
AS |
$28.12 |
$281,200 |
D/D |
(10,000) |
179,285 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-02-01 |
4 |
AS |
$29.19 |
$89,321 |
D/D |
(3,055) |
176,230 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-03-01 |
4 |
AS |
$30.43 |
$93,112 |
D/D |
(3,055) |
173,175 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-05-03 |
4 |
AS |
$30.56 |
$93,361 |
D/D |
(3,055) |
167,065 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-06-01 |
4 |
AS |
$26.24 |
$80,151 |
D/D |
(3,055) |
164,010 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-07-15 |
4 |
OE |
$0.62 |
$5,535 |
D/D |
9,000 |
173,010 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-09-01 |
4 |
AS |
$24.04 |
$300,500 |
D/D |
(12,500) |
160,510 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-11-03 |
4 |
AS |
$24.27 |
$455,791 |
D/D |
(18,780) |
141,730 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-11-04 |
4 |
AS |
$24.33 |
$151,333 |
D/D |
(6,220) |
135,510 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-01-07 |
4 |
OE |
$0.62 |
$17,063 |
D/D |
27,744 |
163,254 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-10-25 |
4 |
AS |
$44.72 |
$558,944 |
D/D |
(12,500) |
163,254 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-10-25 |
4 |
OE |
$6.36 |
$79,500 |
D/D |
12,500 |
175,754 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
19,195 |
182,449 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-12-27 |
4 |
AS |
$49.57 |
$619,609 |
D/D |
(12,500) |
182,449 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-12-27 |
4 |
OE |
$0.62 |
$75,352 |
D/D |
12,500 |
194,949 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
AS |
$54.64 |
$479,560 |
D/D |
(8,777) |
184,911 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-01-03 |
4 |
OE |
$0.62 |
$5,398 |
D/D |
8,777 |
193,688 |
0 |
- |
|
39 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
